Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol

ClinicalTrials.gov ID: NCT00701883

Public ClinicalTrials.gov record NCT00701883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter Randomized Double-Blind Placebo and Active Comparator Controlled Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of MBX-8025 in Moderately Obese Hyperlipidemic Patients With/Out Concomitant Atorvastatin"

Study identification

NCT ID
NCT00701883
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
183 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • MBX-8025 Drug
  • Atorvastatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jun 11, 2015

2007 – 2008

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Radiant Research Birmingham Alabama 35209
Anasazi Internal Medicine Research Phoenix Arizona 85032
Diabetes/Lipid Management and Research Center Huntington Beach California 92648
Radiant Research Santa Rosa California 95405
Clinical Research Consulting LLC Milford Connecticut 06460
Genesis Research International Indianapolis Indiana 46260
Midwest Institute for Clinical Research Inc. Indianapolis Indiana 46260
L-Marc Research Center Louisville Kentucky 40213
Maine Research Associates Auburn Maine 46260
Health Trends Research LLC Baltimore Maryland 21209
Troy Internal Medicine Research Troy Michigan 48098
Bridgewater Medical Group Bridgewater New Jersey 08807
Clifton-Wallington Medical Group Clifton New Jersey 07013
Rochester Clinical Research Albuquerque New Mexico 87108
United Medical Associates P.C. Binghamton New York 13901
Rochester Clinical Research Rochester New York 14609
Southgate Medical Group West Seneca New York 14224
Great Lakes Medical Research Westfield New York 14787
PharmQuest Greensboro North Carolina 27401
Crescent Medical Research Salisbury North Carolina 28144
Piedmont Medical Research Associates Winston-Salem North Carolina 27103
PHA-Adult Medicine Philadelphia Pennsylvania 19146
Radiant Research Greer South Carolina 29651
Tricities Medical Research Bristol Tennessee 37620
Holston Medical Group Clinical Research Kingsport Tennessee 37660
Dallas Diabetes and Endocrine Center Dallas Texas 75230
Diabetes and Glandular Disease Research San Antonio Texas 78229
Walla Walla Clinic Walla Walla Washington 99362

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00701883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00701883 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →